Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
688.95
|
|
Change (%)
|
-8.30 (-1.19%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
688.00
-
700.90
|
|
52-Week Range (RS)
|
660.35
-
860.20
|
|
Beta (1 Year)
|
0.62
|
|
|
|
|
|
| Index Details |
| BSE 500, BSE 200, BSE HC, BSE DOLLEX, BSE SmallCap |
| News |
|
Corporate Details |
| Syngene International Ltd - Syngene International Limited - Copy of Newspaper Publication |
| Syngene International Ltd - Syngene International Limited - Analysts/Institutional Investor Meet/Con. Call Updates |
| Syngene International schedules AGM |
| Syngene International consolidated net profit rises 5.54% in the March 2024 quarter |
| Syngene Intl records PAT of Rs 189 crore in Q4; EBITDA margin at 36% |
| Syngene International Ltd - Syngene International Limited - Outcome of Board Meeting |
| Board of Syngene International recommends final dividend |
| Syngene International Ltd - Syngene International Limited - Updates |
| Syngene International Ltd - Syngene International Limited - Disclosure under SEBI Takeover Regulations |
| Syngene International Ltd - Syngene International Limited - Updates |
|
|
|
| Incoporation Year : 1993 |
| Chairman : Kiran Mazumdar Shaw |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |
| Registered Office |
Syngene International Ltd
Biocon SEZ Biocon Park,
Plot No 2 & 3 Bommasandra Inds,
Bengaluru,
Karnataka-560099 |
Phone:91-80-68915000/67758781
Fax:91-80-28083189 |
| E-Mail : investor@syngeneintl.com; Mayank.Verma@syngeneintl |
| URL : http://www.syngeneintl.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
23-Apr-2024 |
701.20 |
-1.75 |
| 1Month |
01-Apr-2024 |
707.95 |
-2.68 |
| 3Month |
30-Jan-2024 |
716.45 |
-3.84 |
| 6Month |
30-Oct-2023 |
686.35 |
0.38 |
| 1Year |
02-May-2023 |
694.85 |
-0.85 |
|
|
|
|
| Mutual Funds Holding |
|
| Scheme Name |
% Holding |
Market Value (Rs Cr.) |
| Mirae Asset Focused Fund |
3.25 |
273.78 |
| ICICI Pru ELSS Tax Saver Fund |
1.83 |
238.89 |
| ICICI Pru Multicap Fund |
1.98 |
225.13 |
| ICICI Pru Large & Mid Cap Fund |
1.62 |
199.66 |
| UTI-Flexi Cap Fund |
0.81 |
197.58 |
|
|
|
|
| Groups : Pharmaceuticals - Indian - Bulk Drugs & Formln |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Sun Pharmaceuticals Industries Ltd |
1,502.30 |
-1.29 |
1,638.70 |
922.55 |
360,452.09 |
| Cipla Ltd |
1,401.20 |
-0.45 |
1,519.00 |
897.70 |
113,132.18 |
| Dr Reddys Laboratories Ltd |
6,205.10 |
-1.40 |
6,505.50 |
4,383.40 |
103,512.40 |
| Zydus Lifesciences Ltd |
953.60 |
-1.03 |
1,031.30 |
482.55 |
95,954.47 |
| Mankind Pharma Ltd |
2,366.00 |
-0.75 |
2,488.65 |
1,240.75 |
94,779.22 |
|
|
|
|